Hexaware partners with Archimedis Digital to launch QCaaS for life sciences industry

Hexaware Technologies, a provider of IT services and solutions, has collaborated with Archimedis Digital to introduce a new solution called Quality and Compliance-as-a-Solution (QCaaS). This offering is aimed at supporting the life sciences sector in managing quality and compliance while reducing costs and maintaining regulatory standards. 

QCaaS is based on principals from the US Food and Drug Administration’s (FDA) Computerised Software Assurance (CSA) framework, focusing on risk-based validation, critical thinking, and simplified documentation. The solution integrates a digital platform powered by Artificial Intelligence (AI) and generative AI tools to streamline processes such as document generation, risk analysis, and quality reviews. 

The service combines Hexaware’s IT capabilities with Archimedis Digital’s domain expertise in life sciences. It leverages a team of quality and compliance specialists to provide insights that aim to reduce the time and cost involved in verification and validation tasks. The solution is designed to help companies in the BioPharma, MedTech, and related industries achieve quicker product releases and updates, the company said. 

Both companies emphasised the significance of this partnership for addressing challenges faced by the life sciences industry. 

Srinivas Marimganti, Head of Life Sciences & Healthcare, Hexaware Technologies, said, "This collaboration combines Hexaware’s expertise in client solutions with Archimedis Digital’s domain capabilities. We’re excited to bring this capability to the industry, targeted towards driving faster, more reliable outcomes." 

Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital, added, “We have created a Quality & Compliance framework leveraging our years of life sciences industry experience and are in the process of digitising the same.”